<p>The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study</p>-Reference-Cited by-同舟云学术

The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study

Published:2020-08 Issue: Volume:Volume 12 Page:7173-7188
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Guo Linghong,Ren Honghong,Pu Lutong,Zhu Xingyu,Liu Yin,Ma Xuelei^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference61 articles.

1. Hepatocellular carcinoma: a global view

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. European Association For The Study Of The Liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56(4):908–943doi:10.1016/j.jhep.2011.12.001

4. Management of hepatocellular carcinoma: An update

5. Combined interventional therapies of hepatocellular carcinoma

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcatheter arterial chemoembolisation combined with lenvatinib and cabozantinib in the treatment of advanced hepatocellular carcinoma;International Immunopharmacology;2024-03

2. Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD);International Journal of Chronic Obstructive Pulmonary Disease;2024-02

3. PCV‐VG combined individualized PEEP determination in one‐lung ventilated patients with PEEP step change direction: A randomized controlled trial;The Clinical Respiratory Journal;2023-09-18

4. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation;Frontiers in Immunology;2023-03-27

5. Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma;Frontiers in Oncology;2023-01-16